Camptothecins resurface as promising drugs.
Jenks
S
S
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D059004:Topoisomerase I Inhibitors
D059004:Topoisomerase I Inhibitors; D002166:Camptothecin